ISPA:F:F-iShares (DE) I - iShares STOXX Global Select Dividend 100 UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 30.8

Change

+0.15 (+0.47)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-1.25 (-2.39%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-1.48 (-2.56%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.39 (-2.49%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.48B
0ZC:F Zscaler Inc

-3.58 (-1.84%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.74%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing ISPA:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.32% 68% D+ 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.32% 69% C- 61% D-
Trailing 12 Months  
Capital Gain 11.78% 76% C+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.78% 73% C 57% F
Trailing 5 Years  
Capital Gain 40.58% 40% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.58% 40% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain 6.84% 57% F 57% F
Dividend Return 10.28% 66% D+ 57% F
Total Return 3.44% 70% C- 66% D+
Risk Return Profile  
Volatility (Standard Deviation) 12.62% 55% F 85% B
Risk Adjusted Return 81.45% 79% B- 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike